This
meeting was supported by the U.S. Department of Health and Human
Services, Health Resources and Services Administration, Office
of Rural Health Policy under contract number GS23F0087S and HHSH250200716118P.
Please note that comments and recommendations from the Workgroup
Meetings are not officially endorsed by HRSA.
Executive
Summary
This
expert meeting sought to identify ways to improve the translation
and dissemination of border health research produced in the United
States so as to maximize its use by decisionmakers in health policy
and practice. As part of its work to improve access to health
care along the border between the United States and Mexico, the
Health Resources and Services Administration (HRSA) seeks to promote
the use of evidence-based programs and the best available data
and information in planning and providing population-based and
personal health care services. In this context, the term “knowledge
transfer” refers to range of activities designed to link research
to policy and improve the likelihood that policymakers and practitioners
will make evidence-informed decisions.
While
not unique to the border area, the challenges of linking research
to policy in this regional are clearly evident. The report of
the 2002 Border Health Research Agenda Council Meeting declared
that “fragmentation of efforts and lack of communication mechanisms
were identified as the two biggest problems affecting binational
cooperation for health.”
Participants at the HRSA Border Health Summit conducted in August
2006 observed that while the number and variety of research studies
continues to grow, it appears that the knowledge created through
these investigations rarely gets translated into meaningful messages
and disseminated effectively to policymakers, program administrators,
and practitioners. “We know better than we do,” was a consistent
theme.
This
invitational meeting brought together representatives from government
agencies and foundations that fund research, leading researchers
and university officials, health policymakers, program administrators,
and health care providers to examine their experience and discuss
ways to improve the flow of research-based knowledge among stakeholders
at the border. The meeting agenda and participant list are included
in Appendices I and II, respectively.
1. Introduction
Steven
Smith, Senior Advisor to the Administrator, HRSA
Mr.
Smith spoke about the importance of translating research into
practice, as part of HRSA’s broader efforts to reduce health disparities
and improve access to health care services. Feedback from the
HRSA Border Health Summit in August 2006 revealed that participants
were encouraged by the wealth of information presented, but were
troubled that the research was rarely translated into better health
outcomes. HRSA has had promising success in applying health services
research findings to the field of organ donation, where targeted
studies about “best practices” contributed to important policy
changes that increased the number of successful organ donations.
Similarly, Smith said that HRSA hopes to support local leaders
along the U.S.-Mexico border in using research to improve the
delivery and use of health services.
2.
Framework for Assessing Efforts to Link Research to Action
Daniel Campion, AcademyHealth
The
meeting agenda was structured around a framework for assessing
knowledge transfer activities that is being used by the World
Health Organization (WHO). Developed by John Lavis, Ph.D., of
McMaster University and colleagues, the framework is described
in a recent WHO Bulletin article that participants received in
advance of the meeting, along with a worksheet they could use
to reflect upon their own experiences with research transfers
along the U.S.-Mexico border.
Mr. Campion presented the framework as outlined below.
Challenges
in linking research to policy:
- Research
competes with numerous other factors in the policy-making process;
- Research
is not valued as an information input by some policymakers;
- Research
often is not relevant to policy priorities;
- Research
often is not easy to use. It is not communicated effectively
and/or is not available when policymakers need it in a form
that they can use;
- Policymakers
lack mechanisms to prompt them to use research in policymaking;
- Few
forums exist where researchers and policymakers can discuss
policy challenges.
By
addressing these challenges, researchers, policymakers, and foundations
can help ensure that policy decisions are more informed by the
evidence. The WHO framework outlines four steps to overcome knowledge
transfer barriers:
1) Assessing
the general climate for linking research to policy
·
To what extent do universities and research funders
support researchers’ efforts to disseminate their findings and
help policymakers understand and apply them?
2) The
production of research
·
Do research funders take policymakers’ needs into
account when setting priorities for future research?
·
Are systematic reviews being conducted, so as to
synthesize key research findings in priority areas for policymakers?
3) Knowledge
translation and dissemination
·
“Push” efforts include activities to summarize
and deliver research findings to policymakers. Are research producers
identifying actionable messages, fine-tuning messages for different
user groups, delivering findings through credible channels, and
teaching researchers how to communicate their findings?
·
“User Pull” efforts involve policymakers
and health professionals “reaching in” to the research world in
order to inform their decisions. How effective are policymakers
at acquiring, assessing, and applying research? Do they hire analytic
staff, use research findings when making decisions, and participate
in skill-development programs to hone their use of data and research?
·
Efforts to facilitate “User Pull” are activities
initiated by research producers to make it easier for policymakers
to find and use research. For example, is there an electronic
“one-stop shopping” source for optimally packaged high-quality
reviews? Are findings actively distributed, such as through media
coverage?
·
Exchange Efforts include meaningful partnerships
between researchers and policymakers. Are there policy conferences
that discuss recent research findings or learning networks to
facilitate on-going exchanges?
4) Approaches
to Evaluation
·
Rigorous evaluations of efforts to link research
to action are needed. To what extent are these kinds of studies
being funded and are all types of key stakeholders participating
in these evaluations?
3.
The Production and Use of Health Research along the Border
-
Jose Manuel De La Rosa, M.D., U.S.-Mexico
Border Health Commission Member and Vice Dean, Texas Tech
University El Paso School of Medicine.
-
Howard J. Eng, Dr.PH, Assistant Professor, University
of Arizona
-
Martha Medrano, M.D., M.P.H., Director, Medical
Hispanic Center of Excellence, University of Texas Health Science
Center at San Antonio
-
Maria Teresa Cerqueira, M.D., Pan American Health
Organization
Dr.
Manuel de la Rosa spoke about the factors that determine which
research studies impact health policy and practices. He noted
that a study’s academic rigor and conclusions, both of which are
critical foci for the research community, do not affect policy
decisionmakers as much as political climate and packaging techniques.
He also stressed that researchers should take an active role in
health improvement by engaging in responsible research methodologies.
For example, a 1997 Hepatitis A study conducted along the Texas
border involved the vaccination of the populations studied. Dr.
Manuel de la Rosa concluded that academics must be trained so
that they can use their research to help drive policy agendas
and improve the health of the communities that they study. The
research community should also reach out to the communities studied,
to inform them of the value of research and encourage their participation.
Dr.
Eng presented the preliminary results of an ongoing survey
study, which seeks to address the lack of border health research
information. His survey assesses the dominant research areas,
types, locations, sources of funding, collaborations, and publication
types. From the survey results, Dr. Eng has found that the top
5 research areas reported are Access to Care, Diabetes, Cancer,
Maternal and Child Health, and Infectious Diseases. These areas
are all funded primarily by the Federal Government. Academic institutional
collaboration, both domestic and international, has emerged as
a widespread trend. It is also worth noting that, when asked about
the border health research needs, 54 percent of respondents indicated
increased funding; only 15.4 percent called for higher collaboration
and communication efforts. Once the study is completed, Dr. Eng
plans to publish the results in a peer review journal and on the
Southwest Border Rural Health Research Center Web-site.
Following Dr. Eng’s presentation, a few meeting participants offered
comments. One suggestion was to explore whether the dominant research
areas were determined by community needs or by funding sources.
Another was to analyze the survey data by geographical subdivisions,
given the widespread differences within the border area. The participants
agreed that the term “border health researcher” should be defined
– did the study select researchers according to their research
focus or according to the location of their home institution?
Finally, one participant noted that that the existing Institutional
Review Board (IRB) regulations discourage cross-border research
collaboration; researchers must obtain separate IRBs from each
participating institution in order to conduct cross-border studies.
Dr.
Medrano pointed to the importance of research dissemination,
using her experience with the U.S. - Mexico Border Center of Excellence
Consortium as an example. Having noted the need for increased
communication and collaboration within the border health research
community, Dr. Medrano oversaw the creation of a database which
compiled approximately 453 current research programs and projects
on the U.S.- Mexico border. This database has since been incorporated
into the Pan American Health Organization Virtual Library. Dr.
Medrano feels that online libraries and research databases can
act as an intermediary between the researcher and the policy-maker,
increasing the overall accessibility of Best Practices and model
program designs. Such tools also facilitate knowledge management
amongst researchers in the field, allowing for more collaboration
and better targeted studies. The Consortium’s Sharing Model
Curriculum Guidebook will be distributed during the Consortium’s
annual forum in Tucson AZ (August 13 and 14, 2007).
Dr.
Cerqueira described how the Pan American Health Organization
has sought to facilitate collaboration and the practical application
of research. She stated, “it is important that researchers go
beyond simply describing a problem and start offering real solutions.”
Dr. Cerqueira finds that the practical application of research
to policy problems is hampered by research funding silos. She
called for platforms to integrate information, so that social,
environmental, and agricultural research could inform health studies.
She also pointed out that data is collected differently on both
sides of the border, which often hinders binational collaboration.
Finally, to hasten the incorporation of research into policy,
Dr. Cerqueira feels that the border research community should
be more proactive and strengthen the sharing of information using
online resources such as the border virtual health library that
PAHO is supporting. This library is not merely a depository for
information, but actively involves and reaches out to inform a
variety of different border health stakeholders and to encourage
the sharing of research findings. PAHO/WHO is also developing
a global network of people and institutions to encourage the use
of research to strengthen evidence based policy and practice,
known as EVIPNet.
4.
Knowledge Transfers from the Perspective of Policymakers
Elizabeth Duke, Ph.D., HRSA Administrator
Dr.
Duke began by reiterating her personal commitment, and that
of the HRSA, to improving health along the U.S.-Mexico Border.
She explained that Federal agencies like HRSA view research as
a tool to help inform internal decisions, such as the allocation
of funds to support research in special focus areas like oral
health or diabetes. The information sought could either be an
open-ended question, or substantive confirmation of a health trend
that is already generally suspected.
HRSA uses research for three different ends. First, best practices
research informs how HRSA will implement programs and activities
mandated by Congress, hopefully minimizing effort duplication.
Second, research that documents health trends is critical to justifying
the establishment of new programs. For example, HRSA’s anti-bullying
campaign would not exist had substantial research not demonstrated
the connection between bullying and criminal involvement. Finally,
bold research lays the foundation for agenda shifts and changes
in governmental policy. Public servants spend much time and energy
focused on day-to-day implementation; HRSA’s strategic commitment
to research serves as a built-in reevaluation of the Administration’s
overall direction and goals.
Dr. Duke’s advice to researchers seeking to interact with policy
decisionmakers is to pay close attention to information packaging.
“There is a bias in the Federal service towards the practical,
and an unwillingness to talk about theory or methodology. It is
extremely important that researchers learn to talk in an arena
other than their own.” She recommended simplifying the vocabulary
and reducing the content to its bare necessities. She also noted
that Federal Government is a large apparatus that is slow to change;
persistence and leadership are critical.
5.
Workgroups: Ideas for Improving Knowledge Transfer along the
Border
During
the second half of the meeting, participants formed small groups
to discuss possible approaches to improve research-policy linkages.
Because this meeting sought to build on pre-existing work, the
prompts for discussion was based on the WHO
framework described in section
two. These prompts are available in the meeting agenda in Appendix
I. Participants were divided into four workgroups, based on the
four border health research domains identified during the
2002 Border Health Research Agenda Council Meeting. The four workgroup
themes were: (1) Environmental Health, (2) Disease Control and
Prevention, (3) Health Services, and (4) Health, Society, and
Development. Please refer to Appendix III for the workgroup minutes.
6.
Cross-cutting Themes and Opportunities
A
number of cross-cutting themes emerged from the workgroup deliberations,
as listed below.
- The
workgroups were unsure of how to best package and channel
research information for border health stakeholders. Border
communities, researchers, and policymakers collect their information
from different sources and attribute credibility to different
information sources. Participants were particularly unsure of
how to successfully disseminate information to the media and
legislative staffers, intermediaries and information filters
that separate researchers from elected officials. The participants
concluded that researchers needed basic skills training to learn
how to effectively communicate with policymakers.
- Similarly,
some participants questioned whether policymakers and their
intermediaries could not receive training to become
more effective users of research; many cannot assess research
quality and therefore base policies on weak data. Such training
programs could be sponsored by Federal government, States, or
foundations and could target policymakers along the border.
- Researchers
remain objective and unbiased even while actively disseminating
research findings. Several participants warned that the research
community could not become full-fledged advocates or lobbyists
without losing credibility or committing an ethical infraction.
- Some
suggested that border health needs a champion who could
function as a centralized and objective intermediary between
researchers and policymakers and draw attention and resources
to border health. Well versed in the language of both groups,
such a body could compile border research and actively disseminate
it to key decision makers. Perhaps the U.S. Mexico Border Health
Commission could develop a liaison function to help link research
to policy? The U.S. Commission on Social Determinants of Health
was cited as an example of a body that seeks to transfer information
on social determinants of health to policymakers.
- Many
noted that those who fund research can play an important
role in shaping policy changes, both by focusing on policymakers’
priority issues when determining the research agenda and by
improving knowledge transfers. For example, research funders
could encourage researcher collaboration, direct researchers
to study topics that are immediately applicable to interventions,
and “jump-start” researcher-policymaker communication by supporting
research dissemination activities.
- Federal
agencies are the driving force for most border research. Unfortunately,
funding silos and disparate implementation requirements often
hinder cross-sector studies into the underlying causes of border
issues. Meeting participants called for better coordination
and collaboration between the different Federal agencies’
border initiatives.
- Even
though the premise of this meeting was to help U.S. policymakers
and researchers focus on domestic knowledge transfer methods,
some participants expressed concern that Mexican partners
were not invited to the meeting. They noted that any profound
changes in border health will require the collaboration of both
nations. Nonetheless, the participants agreed that some unilateral
work is needed.
7.
Possible Next Steps and Concluding Comments
1.
Convene representatives from Federal agencies involved with
border issues to assess their priorities for health-related research
and approaches for research dissemination. Understanding the
priorities of Federal agencies would help identify where further
research agenda-setting activities (i.e., scoping reviews) and/or
research syntheses may be needed. Bringing together lead staff
from various Federal agencies may also reveal opportunities to
collaborate across agencies, share data, avoid duplication, and
use federal resources more efficiently. More clearly articulating
Federal priorities in this area may help reduce some of the confusion
expressed by several participants at the expert meeting about
federal research projects and help other research funders (e.g.,
states, foundations) target their resources more effectively.
Possible
Approach: We could utilize the existing inter-agency workgroup
as a mechanism for organizing such a conference. Possible participants
might include: HRSA, CDC, AHRQ, CMS, EPA, Dept. of Homeland Security,
Dept. of Agriculture, Dept. of Labor, and Dept. of Justice.
2.
Develop research agendas targeting priority thematic areas, possibly
in partnership with other Federal agencies and research funders.
Each research agenda would map the literature
so as to clarify boundaries and definitions, identify gaps in
evidence, and identify areas where systematic reviews of the existing
literature may be useful. These research agendas would help research
funders identify the most relevant issues to study within priority
thematic areas.
Possible
approach: HRSA would take the lead in identifying priority
thematic areas where policymakers need the most help, possibly
by asking leading policymakers and HRSA grantees about their most
pressing needs over the next few years. This would include Federal
agency officials, the U.S.-Mexico Border Health Commission, State
border health offices, State offices of rural health, county officials,
etc.
3.
Provide skill-development programs/resources for users of border
research. By participating in skill-development programs,
HRSA grantees and other State and local officials would improve
their ability to readily access, understand, and use research
findings in decision making. Currently, there are no federally-sponsored
skill development programs in place for this audience.
Possible
approach: Provide training sessions at relevant HRSA-sponsored
all-grantee meetings, at U.S.-Mexico Border Health Association
meetings, and/or as stand-alone workshops. Programs and materials
developed for border health audiences could also be used for HRSA’s
stakeholders in other parts of the country. Primary audiences
would include border health offices, State offices of rural health,
CHC/FQHC leaders, and other HRSA grantees. Secondary audiences
could include State and local health departments, State legislators
and county commissioners on health related committees, and planning
agencies.
Appendix I
Meeting Agenda
7:00
– 8:00 Breakfast & Registration
8:00
– 8:30 1. Welcome & Introductions
-
Steve Smith, Senior Advisor to the Administrator, Health
Resources and Services Administration
-
Marcia K. Brand, Ph.D.,
Associate Administrator, Office of Rural Health Policy
8:30
– 9:30 2. Knowledge Transfer Framework
The core principles of knowledge transfer will be reviewed and
discussed. - Daniel Campion, AcademyHealth
9:30
– 9:45 Break
9:45
– 11:15 3. Perspectives on Border Health Research
Panelists
will offer their perspectives on the production and use of research
related to health care along the border from the perspectives
of the U.S.-Mexico Border Health
Commission, the Border Centers of Excellence Program, the Pan
American Health Organization, and a recent survey of researchers.
-
Jose Manuel De La Rosa, M.D., Regional
Dean, Texas Tech University
-
Martha Medrano, M.D., M.P.H., Director, Medical
Hispanic Center of Excellence, University of Texas Health Science
Center at San Antonio
-
Howard J. Eng, Dr.P.H., Assistant Professor, University
of Arizona
-
Maria Teresa Cerqueira, M.D., Pan American Health
Organization
11:15
- 11:45 4. Discussion of General Climate for Linking Research
to Action
-
Elizabeth Duke, Ph.D., HRSA Administrator
- Daniel Campion, AcademyHealth
11:45
– 12:30 Lunch Break
12:30
– 2:15 5. Towards a Solution: Breakout Sessions by Research
Domain
Participants
will form small groups related to particular research domains
to discuss possible approaches for overcoming the barriers identified
earlier. The four domains include: 1. Disease control and prevention, 2. Environmental
health, 3. Health services delivery and workforce, 4. Health,
society and development. Possible discussion questions are:
·
Who should be
the primary target audience for this domain of research?
·
What kinds of
decisions are they confronting where research would be useful?
·
To what extent
are research findings available to address these questions?
·
What approaches
have you found most useful for disseminating research findings
to this audience and getting them to use it?
·
What opportunities
exist for improving the exchanges between researchers and decision-makers?
·
Is there a need
for developing a research agenda in this area?
2:15
– 2:30 Break
2:30
– 3:15 6. Pooling the Findings
Participants
will reconvene and hear summary reports from each small group.
3:15
– 4:15 7. Discussion and Identification of Cross-cutting Themes
and Opportunities
-
Facilitated discussion
4:15
– 4:30 8. Possible Next Steps and Concluding Comments
-
Marcia K. Brand, Ph.D.,
Associate Administrator, Office of Rural Health Policy
4:30
Adjourn
Appendix II
Participant List
Hector
Balcazar, Ph.D., M.S.
Regional
Dean/Professor
University
of Texas-School of Public Health
El
Paso Regional Campus
1100
North Stanton, Suite 100
El
Paso, TX 79902
Phone:
(915) 747-8507
Fax:
(915) 747-8512
Email:
hbalcazar@utep.edu |
Joy
Campbell
U.S.
Environmental Protection Agency
1445
Ross Avenue
Dallas,
TX 75202
Phone:
(214) 665-8036
Email:
campbell.joy@epa.gov
|
Daniel
M. Campion, M.B.A.
Director
AcademyHealth
1801
K Street, NW
Suite
701-L
Washington,
DC 20006
Phone:
(202) 292-6700
Fax:
(202) 292-6800
Email:
Daniel.Campion@academyhealth.org |
Frank
Cantu, B.B.A., M.P.A.
Field
Director
Health
Resources and Services Administration
ORHP/DBH
1301
Young Street
Dallas,
TX 75202
Phone:
(214) 767-3171
Fax:
(214) 767-0404
Email:
fcantu@hrsa.gov |
Theresa
Cruz, C.P.A.
Director
Office
of Rural Community Affairs
Austin,
TX 78701
Phone:
(512) 936-6719
Fax:
(512) 936-6776
Email:
tcruz@orca.state.tx.us
|
Maria
Cerqueira, Ph.D., M.Sc., B.S.,
Chief
Border Health Office
Panamerican
Health Organization
World
Health Organization
5400
Suncrest Drive, Suite C4
El
Paso, TX 79912
Phone:
(512) 845-5950, ext. 12
Fax:
(512) 845-4361
Email:
cerqueim@fep.paho.org
|
Erin
Daley, B.A.
University
of Texas at Austin
1200
Barton Hills Drive, #148
Austin,
TX 78704
Phone:
(803) 546-7991
Email:
erinedaley3@yahoo.com
|
Jose
de la Rosa, M.D., M.P.H.
Associate
Dean/Professor of Pediatrics
Texas
Tech University Health Sciences Center
School
of Medicine at El Paso, Texas
Office
of Founding Dean
4800
Alberta Avenue
El
Paso, TX 79905
Phone:
(915) 545-6510, ext. 222
Fax:
(915) 545-6521
Email:
jmanuel.delarosa@ttuhsc.edu
|
Thomas
Donohoe, M.B.A.
Director
UCLA
PAETC
10880
Wilshire Boulevard
Suite
1800
Los
Angeles, CA 90024
Phone:
(310) 794-8276
Fax:
(310) 794-6097
Email:
donohoe@ucla.edu
|
Elizabeth
M. Duke, Ph.D.
Administrator
Health
Resources and Services Administration
Immediate
Office of the Administrator
Dept.
of Health and Human Services
5600
Fishers Lane, Room 14-05
Rockville,
MD 20857
Phone:
(301) 443-2216
Fax:
(301) 443-1246
Email:
BDuke@hrsa.gov
|
Ronald
Dutton, Ph.D.
Director
Texas
Department of State Health Services
Office
of Border Health
1100
West 49th Street
Austin,
TX 78756
Phone:
(512) 458-7675
Email:
rj.dutton@dshs.state.tx.us |
Howard
Eng, Ph.D.
Assistant
Professor
Mel
and Enid Zuckerman College of Public Health
Rural
Health Office
Community,
Environment and Policy
P.O.
Box 245177
1295
North Martin Avenue
Tucson,
AZ 85724
Phone:
(520) 626-5840
Fax:
(520) 626-8009
Email:
hjeng@email.arizona.edu
|
Miguel
Escobedo, M.D.
Quarantine
Medical Officer
CDC
El Paso Quarantine Station
Global
Migration and Quarantine
700
East San Antonio Avenue
El
Paso, TX 79901
Phone:
(915) 533-3568
Fax:
(915) 351-2438
Email:
mxe8@cdc.gov |
Margarita
Figueroa Gonzalez, M.D.,
M.P.H.
Health
Resources and Services Administration
ORHP/DBH
1301
Young Street
Dallas,
TX 75202
Phone:
(214) 767-3171
Fax:
(214) 767-0404
Email:
mfiguero@hrsa.gov
|
Antonio
Furino, Ph.D.
Associate
Director
Center
for Health Workforce Studies
UT
Health Science Center at San Antonio
7703
Floyd Curl Drive, MSC 7907
San
Antonio, TX 78229
Phone:
(210) 567-3168
Fax:
(210) 56-3168
Email:
penaj@uthscsa.edu
|
Hector
Gonzalez, M.D., M.P.H.
Director
of Health
City
of Laredo
Health
Department
2600
Cedar Avenue
Laredo,
TX 78040
Phone:
(956) 795-4901
Fax:
(956) 726-2632
Email:
hgonzalez@ci.laredo.tx.us
|
Robert
Guerrero, M.B.A.
Chief
Arizona
Department of Health Services
Public
Health Services
Office
of Border Health
440
East Broadway, Suite 300
Tucson,
AZ 85711
Phone:
(520) 770-3110
Fax:
(520) 770-3307
guerrer@azdhs.gov |
Alison
Hughes, M.P.A.
Director
RHO
Flex Program
MEZCOPH
University
of Arizona
1295
North Martin Avenue
Tucson,
AZ 85724
Phone:
(520) 626-6253
Fax:
(520) 626-3101
Email:
ahughes@u.arizona.edu |
Harvey
Licht, M.S.
Director
Primary
Care/Rural Health Office
Health
Systems Bureau
New
Mexico Department of Health
300
San Mateo NE, Suite 900
Albuquerque,
NM 87108
Phone:
(505) 841-5869
Fax:
(505) 841-5885
Email:
Harvey.licht@state.nm.us
|
Alma
Martinez-Jimenez, M.S.
University
of Texas at San Antonio
Institute
of Demographic and Socioeconomic Research
One
UTSA Circle
San
Antonio, TX 78249
Phone:
(210) 458-6084
Email:
alma.martinez@utsa.edu
|
Lisa
McAdams, M.D., M.P.H.
Medical
Officer
Centers
for Medicare and Medicaid Services Consortium for Quality
Improvement
and Survey and Certification Operations
1301
Young Street, Room 833
Dallas,
TX 75202
Phone:
(214) 767-6456
Fax:
(214) 767-6454
Email:
lisa.mcadams@cms.hhs.gov |
Joseph
McCormick, M.D.
Regional
Dean
UT
Houston Health Science Center at
Houston
School
of Public Health Brownsville Campus
80
Fort Brown, SPH Building, Room N. 200
Brownsville,
TX 78520
Phone:
(956) 882-5166
Fax:
(956) 882-5152
Email:
joseph.b.mccormick@utb.edu
|
Martha
Medrano, M.D., M.P.H.
Director
The
University Health Science Center of
San
Antonio
The
Office of the Dean
Medical
Hispanic Center of Excellence
7703
Floyd Curl Drive
San
Antonio, TX 78229
Phone:
(210) 567-0963
Fax:
(210) 567-0974
Email:
medranom@authscsa.edu
|
Michael
Meit, M.A., M.P.H.
Senior
Research Scientist
National
Opinion Research Center
Health
Policy and Evaluation
7500
Old Georgetown Road, Suite 620
Bethesda,
MD 20814
Phone:
(301) 951-5076
Fax:
(301) 951-5082
Email:
meit-michael@norc.org
|
Michelle
Mellen, B.S.
Health
Resources and Services
Administration
ORHP/DBH
1301
Young Street, Room 1014
Dallas,
TX 75202
Phone:
(214) 767-3070
Fax:
(214) 767-0404
Email:
mmellen@hrsa.gov
|
Jacob
Nevarez, M.S.
Environmental
Health Epidemiologist
New
Mexico Department of Health
Office
of Border Health
1170
North Solano, Suite L
Las
Cruces, NM 88001
Phone:
(505) 528-5152
Email:
Jacob.nevarez@state.nm.us
|
Larry
Olsen, Ph.D.
Associate
Dean
New
Mexico State University
College
of Health and Social Services
1335
International Mall, MSC 3446
P.O.
Box 30001
Las
Cruces, NM 88003
Phone:
(505) 646-2064
Fax:
(505) 646-6166
Email:
lolsen@nmsu.edu |
Patti
Patterson, M.D., M.P.H.
Vice
President
Texas
Tech University Health Sciences
Center
Rural
and Community Health
3601
Fourth Street, MS 6232
Lubbock,
TX 79430
Phone:
(806) 743-1338
Fax:
(806) 743-4510
Email:
patti.patterson@ttuhsc.edu
|
Ann
Pauli, C.P.A., M.B.A.
President/CEO
Paso
del Norte Health Foundation
1100
North Stanton Street, Suite 510
El
Paso, TX 79902
Phone:
(915) 544-7636
Fax:
(915) 544-7713
Email:
ssoto@pdnhf.org |
Nelda
Perez, B.A., M.A.
Environmental
Protection Specialist
Environmental
Protection Agency
Office
of Environmental Justice and Tribal Affairs
1445
Ross Avenue
Dallas,
TX 75202
Phone:
(214) 665-2209
Fax:
(214) 665-6684
Email:
perez.nelda@epa.gov
|
Rebeca
Ramos, M.A.
Executive
Director
U.S.
Mexico Border Health Association
5400
Suncrest - 5C
El
Paso, TX 79912
Phone:
(915) 833-6450
Email:
rebeca@utep.edu |
Dan
Reyna
General
Manager
US
Section, Border Health Commission
Office
of Global Health Affairs
Health
and Human Services
201
East Main Drive, Suite 1616
El
Paso, TX 79901
Phone:
(915) 532-1006
Fax:
(915) 532-1697
Email:
dan.reyna@hhs.gov
|
Elizabeth
Rezai-zadeh, M.P.H.
Public
Health Advisor
Health
Resources and Services
Administration/ORHP
Department
of Health and Human Services
5600
Fishers Lane, Room 9A-55
Rockville,
MD 20857
Phone:
(301) 443-4107
Fax:
(301) 443-2803
Email:
erezai@hrsa.gov |
Alfonso
Rodriguez-Lainz
Chief
Scientist
California
Office of Binational Border Health
California
Department of Health Services
Prevention
Services
5353
Mission Center Road, Suite 215
San
Diego, CA 92108
Phone:
(619) 688-0178
Fax:
(619) 688-0281
Email:
arodrigu@dhs.gov
|
Lilia
Salazar
Border
Health Officer
Health
Resources and Services Administration
ORHP/DBH
1301
Young Street, Suite 1014
Dallas,
TX 75202
Phone:
(214) 767-3073
Fax:
(214) 767-0404
Email:
lsalazar@hrsa.gov
|
Carmen
Sanchez-Vargas, M.D., M.P.H., M.Sc.
CDC
Liaison to the USMBHC
Coordinating
Office of Global Health
201
East Main Drive, Suite 1616
El
Paso, TX 79901
Phone:
(915) 532-1006
Fax:
(915) 532-1697
Email:
czs4@cdc.gov
|
Paula
Selzer
Asthma
and Children’s Environmental Health
U.S.
Environmental Protection Agency
Region
6
1445
Ross Avenue, 6PD-T
Dallas,
TX 75202-2733
Phone:
(214) 665-6663
Fax:
(214) 665-6762
Email:
selzer.paula@epa.gov
|
Steven
Shelton, M.B.A.
Assistant
Vice President
Community
Outreach
East
Texas AHEC
301
University Boulevard, Rt. 1056
Galveston,
TX 77555
Phone:
(409) 772-7884
Fax:
(409) 772-7886
Email:
steve.shelton@utmb.edu
|
Stephen
R. Smith
Senior
Advisor
Health
Resources and Services Administration
Office
of the Administrator
Department
of Health and Human Services
5600
Fishers Lane
Rockville,
MD 20857
Phone:
(301) 443-2194
Fax:
(301) 443-1246
Email:
ssmith3@hrsa.gov
|
Hugo
Vilchis, M.D., M.P.H.
Director
and Associate Professor
New
Mexico State University
Border
Epidemiology Center
P.O.
Box 30001, MSC 3BEC
Las
Cruces, NM 88003
Phone:
(505) 646-3057
Fax:
(505) 646-8131
Email:
hvilchis@nmsu.edu/~bec
|
Gina
Weber, M.P.A.
U.S.
Mexico Border Coordinator
U.S.
Environmental Protection Agency
1445
Ross Avenue, Suite 1200
Dallas,
TX 75202
Phone:
(214) 665-6787
Fax:
(214) 665-7263
Email:
weber.gina@epa.gov |
Erma
Woodard
Special
Assistant
Health
Resources and Services
Administration
ORHP/DBH
1301
Young Street, 10th Floor
Dallas
TX 75202
Phone:
(817) 791-0183
Fax:
(214) 767-0404
Email:
ewoodard@hrsa.gov |
Maria
Luisa Zuniga, Ph.D.
UCSD
Family
and Preventive Medicine
9500
Gilman Drive, Department 0927
La
Jolla, CA 92093
Phone:
(619) 681-0689
Email:
mzuniga@ucsd.edu
|
Miguel
Zuniga
Director
Texas
A&M Health Science Center/South Texas Center
McAllen
2101
South McColl Road
McAllen,
Texas 78503
Phone:
(956) 668-6311
Fax:
(956) 668-6301
Email:
mzuniga@tamhsc.edu
|
Appendix III
(1)
Environmental
Health Workgroup
Present:
R.J. Dutton (Facilitator), Gina Weber (Recorder), Larry Olsen,
Elizabeth Rezai-Zadeh, Alfonso Rodriguez, Paula Selzer, Joy Campbell,
Jacob Nevarez, and Hugo Vilchis.
1.
Identifying Stakeholders
EPA,
HHS, U.S. Department of Agriculture, Foundation (Paso del Norte,
California Endowment, Medows, etc.), NIH, Congressional Delegation,
states, locals, private sector, and NGO’s. Intermediaries include
policy centers, USMBHC, USMBHA, PAHO and NGOs.
Who
are the users? Policymakers, such as legislatures, elected
officials, agencies, health departments, U.S.-Mexico Border Health
Commission, County Commissioners, and Congress.
Who
are the producers? Universities, Department of Health, community
organizations, and hospitals.
2.
Production of Research
What
could be done to improve the relevance of research in this domain
area?
The
principle function of Research Faculty is to perform research
studies, irrespective of the needs of the community. Who decides
what the priorities are?
•
All the stakeholders need to come together
•
Communities need to be asked
•
What is the impact of the research?
•
What happens to the research?
•
We want to use the knowledge
How
to improve?
•
Value in the kind of publications
•
Make information more relevant
•
Funding needs to come from the institutions as well. Funding
up front for needs that are known to exist.
•
The users need to be investing on their own.
•
Have policymakers be engaged in the development of the
research,
•
Supporting community based research.
•
Academic versus community based should be equalized.
•
Focused on how universities operate in the community.
•
Researchers need to interface with the users of the research.
•
What are the specific issues of the border? What makes
an issue a border issue?
•
Use of systematic reviews. Understanding what it means.
Solutions.
•
Scientific base needs to be interpreted.
•
Communities want transparency in the results.
•
Community feels that researchers need them, but only to
“use” them.
•
Identify gaps in information.
3.
Knowledge Transfer Mechanisms
•
Transfer technical skills to layman’s terms.
•
Integrity and transparency in research and results.
•
More communication with legislators on the border. How
to assist them with information they need to make decision. Be
proactive in asking them what they need.
•
Statistical versus practical - need to publish issues that
are applicable.
•
Impact policymakers to invest in the border.
•
Capacity building.
•
Community responsibility:
·
Academics need research done, and communities feel
that they get the information and then leave with no follow up
or information.
·
Responsibility with the community.
·
Transfer knowledge to the community. Give them their
own responsibility.
·
Agency funding needs to make those a requirement
for funding.
·
Evidence based work.
·
Developing local leadership.
·
What information and how to use it to make decisions.
•
Use more MAP-IT (Mobilize, Assess, Plan, Implement, and
Track)as an example. MAP-IT is a CDC Program for community health
promotion.
•
Promotion model (knowledge transfer model).
•
Social Marketing/health promotion use common message to
solve issues.
ºSide
Discussions not on the outline, but relevant to the assigned task:
Discussion
regarding the definition of the border among the participants.
Participants discussed what is the border? Geography, binational,
and relevant border research that can be done anywhere else or
just at the border?
What
is an example of a successful program? Such as Border 2012 Program
led by the EPA. Define what is border health as opposed to health
in general. Transparency and integrity as key issues in the border.
(2)
Disease
Control and Prevention Workgroup
Present: Dr. Patti Patterson (Facilitator), Tom
Donohoe (recorder), Dr. Miguel Escobedo, Dr. Margarita Figueroa-Gonzalez,
Mr. Robert Guerrerro, Ms. Alizon Hughes, Dr. Jospeh McCormick,
Dr. Carmen Sanchez-Vargas, Dr. Maria Luisa Zuniga, Mr. Thomas
Pack.
Themes throughout discussion:
U.S.
border providers tell us in needs assessments (and conversations,
work, etc) whatever we do we need to involve their Mexican counterparts,
but HRSA legislative authority prohibits it. Changing this inability,
or moving toward more binational work, would be beneficial to
U.S. providers.
Other Federal agencies, including but not
limited to the CDC, need to be more organized and responsive to
border health research needs and issues. It’s not just a HRSA
issue and coordination on the border at the Federal level between
agencies seems to be lacking. Coordination would have many benefits,
including possible translational research.
We need to align resources (that serve different
areas) at the border
·
Federal
funds are like the children’s serving plates with dividers (so
the food can’t touch). So panflu can’t touch AIDS can’t touch
infectious, etc.
·
Allow
more flexibility in using funds and stop reinventing the wheel
Funding and programs are siloed. Teen pregnancy,
substance abuse, childhood obesity. All have common roots. All
are behaviors that are trying to fill a void. Kids more likely
to be obese if abused, etc. But we treat programs differently.
We need to make programs come together that focus on people and
these roots (ie, adverse childhood experiences). If we don’t look
at things comprehensively, it’s like fulfilling the definition
of insanity…
How can we move toward “institutionalization
of cross-border inclusivity” in infectious disease? Where are
our colleagues from Mexico?
·
One
thought: funding might come from bioterrorism (where joining forces
has clear benefits and attention/resources currently exist.
Conversation about stakeholders:
·
Communities
in general (groups, schools, faith-based, families, binational–
wasn’t prevalent in materials sent out)
·
Providers
(for profit, nonprofit, new HMOs, etc)
·
Federal
government
o Funds
·
State
government
·
Local
government
·
Tribal
·
Binational
sewn through everything we’re doing
o Diplomatically, you have to be careful when
showing data on a problem the Mexican side may be downplaying
o Binational collaboration is important, but
there’s a lot we can do unilaterally on this side.
§
We have
our own share of politics and problems
o You may not be successful at getting Mexican
counterparts to participate.
·
Schools
·
Business/industry
(need to link with their goals…discussion of need for immigrant
labor despite anti-immigrant paradox)
o HMOs/ins
o Agriculture
o Chamber of commerce
·
Faith-based
·
Social
groups
o Rotary
o ULAC
o Lion’s
·
Law
enforcement (INS, local…)
·
Government
(Fed, State, local…Need to work with legislators through their
staffers)
·
Providers
o For profit/non profit hospitals
o CHCs
o Social service agencies
Border doesn’t stop at the border (Migration
is often the issue and it is national)
·
Colonias
on the border get money, colonias not on the border don’t
·
Idea
of the “Border Impact Zones.”
What can be done to improve the relevance
of research in this domain area?
·
Lack
of collaboration and coordination in funding and leadership
·
Focus
on border and health disparities
·
Need
to correct misinformation (terrorism and immigration link, migrants
arrive with health needs and this damages economy, etc) and research
unintended consequences of laws/proposed laws (i.e., even if a
law is not passed some immigrants may not seek health services
given their new perceptions)
·
What’s
different? What separates these disparities from other disparities?
·
Not
funded to collaborate – sometimes even punished – though collaboration
is a growing trend in, for example, NIH grants
·
Need
to involve community to make research relevant.
·
Coordination
of Federal agencies/funding, with specific funding going to collaborative
efforts (CDC, SAMHSA, HRSA, etc)
·
Funding
should also emphasize sustainability, especially if project is
delivering health resources
·
Research
should be translational/transorganizational (NIA, USDA, HRSA,
SAMHSA, NIDA, EPA, NIH, etc)
·
Needs
to be proactive (rather than reacting to current ‘immigration’
other perceived ‘crisis’)
·
Needs
to help answer question “How do we take what we know/learned and
make it work at the community level?’
·
Need
to emphasize benefits to funders, national, communities (lowered
costs, better health, etc)
·
Need
to anticipate giving information back to stakeholders through
official and unofficial dissemination strategies (i.e., one-page
preliminary data summaries for staffers (or maps, pictures, story
telling…), and other crafted messages for specific audiences.
Radio might be best for immigrant pops, for example. Such campaigns
could be evaluated for effectiveness.)
(3)
Health
Services Group Meeting
Present:
Harvey Licht (Facilitator), Michael Meit (Recorder), Mrs Theresa
Cruz, Dr. Jose de la Rosa, Dr. Howard Eng, Dr. Antonio Furino,
Ms. Alma Martinez-Jimenez, Dr. Lisa McAdams, Mr. Steve Shelton,
Ms. Nina Meigs
I.
The Who.
-
Stakeholders: Program administrators, policymakers, legislators
(elected officials at all levels), health-related organizational
leaders (associations, cancer society, etc), appointed agency
heads (not elected), health care provider organizations, other
researchers, funding agencies, advocacy groups, universities and
educational groups, community residents, private citizens, hospitals.
Who
are the most important audiences for border health research?
(1)
Legislators (elected),
(2)
Provider leaders (corporate, people who make decisions about
how the system works),
(3)
Funding agencies (whether government or not, because money
drives how research works)
(4)
Government agencies (depends on how think of funding agencies,
sometimes they come to us, sometimes we go to them)
(5)
Advocacy groups. Not necessarily health organizations; also
organizations such as AARP, for example.
“It
all comes back to the funding, the money allocated drives the
agenda.” But the other researchers are important too. There’s
no money in rural health research, but we have been able to leverage
other funds to use to address rural issues. While it would be
nice, there doesn’t have to be a designated border ‘pot.’- Harvey
Licht
What’s
the information seeking behavior of these groups? Where do you
think a key elected official would get their information? Where
do they get their agenda, their view of the world, how do they
know something’s a problem? Web sources, human sources, organizational
sources, printed sources? Should we send them information, or
go through a special intermediary (published, human etc.)?
-
State Agencies that deal with the issues
-
Individuals/constituents - The number of voters
who contact an elected official has a very strong impact. Because
they only see the importance of the issue from the perspective
of the person who brings it to their attention
-
Special interest groups - could be health providers,
specialty organizations. The stakeholder has a level of credibility.
-
Content experts
-
Media
-
Association of State legislator – peers
-
Special Inquiry or directives
“Our
elected officials are only as good as the information they have
to work with.” -Unknown
How
do legislators balance credibility vs. importance?
“Granted,
people are elected because have strong views. Researchers need
to know their audience, who they’re going to take their information
to. Some politicians are more open to veering from the party stance.
The researcher needs to know the individual, not just the legislator
as a class of people.”
-Unknown
Let’s
look at the provider organizations. Where do they get their information?
-
Health related organizations
-
Citizens
-
Universities
“I’m
amazed how many professional organizations don’t use their own
data”.
-Unknown
Where
do Government Agencies and Funding groups get their information?
-
Internal - Staff telling them what is important.
There are lots of internal data sources.
“It
is interesting that we haven’t mentioned journals. These various
stakeholders don’t review the literature. Most information comes
from a limited set of channels, mediated by a group of individuals.”
-Unknown
We
have Policy makers and Information producers. There’s the stuff
provided, and there’s the requests/inquiries made. Can you think
of one or two cases, where information was effectively transmitted
to one of those key policy makers? Information about the existence
of a problem, or an intervention.
-
“We identified a lack of physicians in El Paso, so we built
a Medical School. We gathered data, bombarded multiple sources
of information with the data, and consistently presented that
as the solution to the problem of health profession shortage,
and economic impact, and several other problems. What finally
did it was that we presented our solution as a response to several
different problems, and we used brute force.” – Dr. Manuel J.
de la Rosa
-
Economic Impact and job creation are top interests
for legislators, so it is helpful to relate your measure to these
interests.
-
Nonetheless, consider ethical issues. Research should
be done to answer a question. Is your research being influenced
in order to substantiate a desired outcome? Influencing policy
sets up a delicate line, when you’re no longer a researcher. Policy-makers
may then question your credibility and your data, if they’re experienced.
Make sure your information has not been tainted by the bias.
We’ve
talked about Who, about what kind of information comes at them,
the variety of ways they seek information, and how we can communicate
what we do to them. The bottom line: What would we recommend as
information producers?
-
So much comes from staff members. Do something nice
for them such as a dissemination or a briefing package, aimed
at the staff of key legislatures.
-
Build a personal relationship, and you become a resource
to them. You need a sponsor to get a meeting. You can build
on a relationship that you establish.
-
Help them to be effective research consumers, to assess
the quality of research. One of our problems is that these
studies say going one direction, then one studies differs. That
study may have flaws.
-
Include a dissemination plan as part of the research
process.
-
The rural health round tables that used to be held
were effective. Interested folks would come to these; they served
as an educational tool with a robust interchange of information.
-
Create a US Mexico Health Commission that actually is
housed in Washington, as a quasi-federal agency, with a separate
appropriation from congress, as was originally envisioned. Instead
it become a subsection of Office of Global Health Affairs. The
Appalachian Regional Commission may be a model. It defined a region
and, described the issues within that region. This was a major
contribution to help shape policy. While the US-Mexico Border
Region is recognized, the difference is that ARC is a free-standing
government agency whose mission is to draw attention and resources
to that region. At the very least, there should be a Washington
liaison office working to build relationships
-
Reorganize HRSA’s regions to create a “region 11”
that includes only the border states. Focus on area as an organizational
entity.
-
Centralize border resources. Create a “carve-out”
of HRSA’s activities, in terms of research and entities. Not taking
away anyone’s dollars, but centralizing across all interventions
and research.
-
Recognize that the border is bi-national/tri-national.
To separate it out to see states just north of the line is insufficient
acknowledgement. It is really hard to have a border meeting without
our colleagues from Mexico. It doesn’t do justice to the whole
thing.
-
Demonstrate to other states why this is important to
them from a financial aspect. Cite that drug-resistant TB
guy. That’s the reality of the world that we live in. The border
states are more affected, but must create compelling interest
among others.
To
summarize, expansion of Border Health Commission function to include
research and, more importantly, to compile that information and
make it available through a new structure to key decisionmakers
at State and Federal level. This would be followed by a consolidation
and reorganization of federal program resources to help target
those resources to the specific needs identified across the border.
(4)
Health,
Society & Development Workgroup
Present: Dr. Hector Balcazar
(Facilitator), Ms. Erin Daley (Recorder), Ms. Michell Mellen,
Dr. Maria Elena Ruiz, Ms. Lisa Cacari Stone, Mrs. Lilia Salazar,
Ms. Rebecca Ramos, Dr. Maria Cerqueira
General
Climate for Linking Research to Policy
Stakeholders
In
looking at health, society and development with relationship to
border health research knowledge transfer, the range of stakeholders
is very broad, ranging from those at all levels of government
to individual civil society organizations as well as collaborative
bodies. At the Federal level, the Department of Health and Human
Services (DHHS) and its composite agencies, such as HRSA, CDC,
NIH, ACF and others are stakeholders in this effort as are agencies
without an exclusive focus on health such as the Department of
Agriculture, Department of Homeland Security, USAID and the Environmental
Protection Agency. Additionally, Federal and local legislators,
local governments at the city, county and State level, civil society
organizations, universities and other collaborative groups such
as the state Primary Care Associations and the National Governors
Association all have a stake in this work. We need to determine
what the interest of each stakeholder is and how they want to
be involved and it may be useful to map the interests and efforts
of different stakeholders. Since September 11, 2001, the increased
policy focus on homeland security has brought in new stakeholders
and there is a need for multisectoral play. Additionally there
may be a mismatch of who the community considers stakeholders
and who researchers may see as stakeholders. The community really
needs to be brought into the process so that we are working together
as equal partners.
Production
of Research
The
production of research is highly dependent upon funding opportunities
and thus, there is a lot of politics that goes into what gets
funded for research. There are also biases related to gender and
culture that affect which research gets funded and even what research
gets disseminated (via publication in a peer-reviewed journal).
There is also a tendency to want to continue on the same path
that we’ve always been on in terms of funding the same types of
organizations. For example, scholars working in non-academic settings
may be less likely to receive funding for research as they are
seen as less capable. Additionally, there is a tendency to continue
funding the same broad research areas as well. For example, the
community of stakeholders in the infectious disease agenda is
stronger than in other areas, so trying to shift to funding more
research related to chronic diseases and socio-determinants of
health can lead to a lot of resistance.
Conducting
a systematic review of what research has been done on the border
may not answer the questions we really need to answer. In many
areas, there has not been enough research in order to conduct
a systematic review. We cannot just be limited to metanalysis,
but also need to consider community anecdotes that represent promising
ideas. We also need to make bold changes in the way research is
conducted and the theoretical models we use. Some specific recommendations
on how to move forward follow:
·
Look directly at the funding sources to get data
on research production. For example, studying how much DHHS funding
is going into research related to the border.
·
Promote research that can be directly applied to
interventions. For example, we know that there is a current shortage
of Hispanic health workers, even in many border areas with a high
percentage of Hispanic residents. We need to make the link between
this knowledge and real possibilities to increase the health care
workforce.
·
Utilize less traditional qualitative research methods.
For example, you can reach people in El Paso / Juarez by talking
to people while they are riding the bus or sitting in a plaza.
·
Promote research that is framed from a social justice
perspective and can lead to social change by:
o
Basing funding priorities on the issues identified
as being of importance by the community.
o
Researching the root causes of the problems, even
if this is difficult given the political climate.
o
Considering the effect of our research on the communities.
Many times research labeled as Community Based Participatory Research
still ends up being one-sided in which the researchers do not
leave anything behind and the community is not empowered.
o
Studying assets and resiliencies in the communities
instead of focusing exclusively on risks and deficits.
Knowledge
Transfer Activities
The
process of transferring knowledge is twofold. First, one must
convert data into information and then take information and make
it into knowledge. Power is one of the most important factors
in how information is relayed. We advocate a more reciprocal term
to describe the relationship between researchers and policy-makers
and will speak of “knowledge exchange” instead of “knowledge transfer,”
as the latter term implies that one side has all the knowledge
and it is sent in one direction. It is not just one side “pushing”
or the other side “pulling,” but instead we should view this as
a circular process.
The
traditional thinking has been that the physicians are the most
appropriate to conduct research and communicate its results. However,
there are people in many other areas that should be engaged and
have unique talents to contribute to the process. This should
really be a multidisciplinary effort.
Recommendations
for possible future action include:
·
Disseminate research through mechanisms that are
already in existence. For example, the Robert Wood Johnson Foundation
is currently funding the U.S. Commission on Social Determinants
of Health, a commission aimed at transferring information on social
determinants of health to policymakers.
·
Work with media professionals to turn peer-reviewed
publications into press releases for local papers so that the
information gets into the mainstream media.
·
Identify possible high profile champions who may
want to advocate for border issues so that the issues receive
more attention.
·
Create a media award to celebrate and encourage
good reporting.
·
Contact networks such as governor networks or legislator
networks to better understand how they use information and then
evaluate how that matches what we produce.
·
Create ongoing opportunities for knowledge dissemination
and to bring together stakeholders.
Workgroup
Conclusions
Our
border is looked at around the world as an example and there is
a lot of capacity on the border in terms of people. However, the
border area ranks as the lowest in the country with respect to
many different health measures. The border States need to publicize
this issue and emphasize the issues that are unique to the border.
We need to look beyond just how knowledge is produced to see how
it is exchanged as well. As researchers, we also need to look
for other paradigms outside of the framework of silos that we
have been looking at. It is important to think outside of the
box and not just develop more of the same and we must include
all the relevant players. We should continue to build on the binational
work that was recently done at the U.S.-Mexico Border Health Commission
meeting in Monterrey, Mexico in October 2006 as well as other
binational work that has been done in other venues in order to
remain in constant conversation with our colleagues in Mexico
as the issues are truly binational.